Role of RNA structural plasticity in modulating HIV-1 genome packaging and translation.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
13 Aug 2024
Historique:
medline: 8 8 2024
pubmed: 7 8 2024
entrez: 7 8 2024
Statut: ppublish

Résumé

HIV-1 transcript function is controlled in part by twinned transcriptional start site usage, where 5' capped RNAs beginning with a single guanosine (1G) are preferentially packaged into progeny virions as genomic RNA (gRNA) whereas those beginning with three sequential guanosines (3G) are retained in cells as mRNAs. In 3G transcripts, one of the additional guanosines base pairs with a cytosine located within a conserved 5' polyA element, resulting in formation of an extended 5' polyA structure as opposed to the hairpin structure formed in 1G RNAs. To understand how this remodeling influences overall transcript function, we applied in vitro biophysical studies with in-cell genome packaging and competitive translation assays to native and 5' polyA mutant transcripts generated with promoters that differentially produce 1G or 3G RNAs. We identified mutations that stabilize the 5' polyA hairpin structure in 3G RNAs, which promote RNA dimerization and Gag binding without sequestering the 5' cap. None of these 3G transcripts were competitively packaged, confirming that cap exposure is a dominant negative determinant of viral genome packaging. For all RNAs examined, conformations that favored 5' cap exposure were both poorly packaged and more efficiently translated than those that favored 5' cap sequestration. We propose that structural plasticity of 5' polyA and other conserved RNA elements place the 5' leader on a thermodynamic tipping point for low-energetic (~3 kcal/mol) control of global transcript structure and function.

Identifiants

pubmed: 39110735
doi: 10.1073/pnas.2407400121
doi:

Substances chimiques

RNA, Viral 0
RNA Caps 0
RNA, Messenger 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2407400121

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI150498
Pays : United States
Organisme : HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : U54 AI70660
Organisme : NIAID NIH HHS
ID : R01 AI110221
Pays : United States
Organisme : NIAID NIH HHS
ID : F30 AI174890
Pays : United States
Organisme : HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
ID : 5T32 HL007698-26

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Saif Yasin (S)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

Sydney L Lesko (SL)

Department of Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53705.
Department of Oncology, Institute for Molecular Virology, University of Wisconsin-Madison, Madison, WI 53705.

Siarhei Kharytonchyk (S)

Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109-5620.

Joshua D Brown (JD)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

Issac Chaudry (I)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

Samuel A Geleta (SA)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

Ndeh F Tadzong (NF)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

Mei Y Zheng (MY)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

Heer B Patel (HB)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

Gabriel Kengni (G)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

Emma Neubert (E)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

Jeanelle Mae C Quiambao (JMC)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

Ghazal Becker (G)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

Frances Grace Ghinger (FG)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

Sreeyasha Thapa (S)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

A'Lyssa Williams (A)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

Michelle H Radov (MH)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

Kellie X Boehlert (KX)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

Nele M Hollmann (NM)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.
HHMI, University of Maryland, Baltimore County, MD 21250.
Department of Chemistry and Biochemistry, University of Maryland, Baltimore, MD 21250.

Karndeep Singh (K)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

James W Bruce (JW)

Department of Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53705.
Department of Oncology, Institute for Molecular Virology, University of Wisconsin-Madison, Madison, WI 53705.

Jan Marchant (J)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.

Alice Telesnitsky (A)

Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109-5620.

Nathan M Sherer (NM)

Department of Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53705.
Department of Oncology, Institute for Molecular Virology, University of Wisconsin-Madison, Madison, WI 53705.

Michael F Summers (MF)

Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD 21250.
HHMI, University of Maryland, Baltimore County, MD 21250.
Department of Chemistry and Biochemistry, University of Maryland, Baltimore, MD 21250.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH